Kenya eClaims FHIR IG
0.1.0 - ci-build
Kenya eClaims FHIR IG
0.1.0 - ci-build
Kenya eClaims FHIR IG - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="866d4b06-9199-41a1-9ea9-213212ea9512"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationRequest 866d4b06-9199-41a1-9ea9-213212ea9512</b></p><a name="866d4b06-9199-41a1-9ea9-213212ea9512"> </a><a name="hc866d4b06-9199-41a1-9ea9-213212ea9512"> </a><p><b>identifier</b>: <code>https://shr.dha.go.ke/fhir/medication-request</code>/bcb292cb-0707-4b90-8c35-39a82ed0f389 (use: official, )</p><p><b>status</b>: Active</p><p><b>intent</b>: Order</p><p><b>medication</b>: <span title="Codes:{http://nhts.dha.go.ke/fhir/ValueSet/medication GE10887}">Atorvastatin 20mg tablet</span></p><p><b>subject</b>: <a href="Patient/CR6164711105276-6">Patient/CR6164711105276-6</a></p><p><b>authoredOn</b>: 2025-06-30</p><p><b>requester</b>: <a href="Practitioner/PUID-0001662-7">Practitioner/PUID-0001662-7</a></p><p><b>reasonCode</b>: <span title="Codes:{https://nhts.dha.go.ke/terminology/icd11 I10}">Essential (primary) hypertension</span></p><p><b>note</b>: </p><blockquote><div><p>Patient has reported nausea with higher doses in the past.</p>
</div></blockquote><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: Take one tablet by mouth daily</p><p><b>timing</b>: Once per 1 day</p><p><b>route</b>: <span title="Codes:{https://nhts.dha.go.ke/terminology/v1/route RT10025}">Oral</span></p><h3>DoseAndRates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Dose[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/dose-rate-type ordered}">Ordered</span></td><td>20 milligram per dose<span style="background: LightGoldenRodYellow"> (Details: unit codeUM10229 = 'UM10229')</span></td></tr></table></blockquote><blockquote><p><b>dispenseRequest</b></p><p><b>validityPeriod</b>: 2025-03-28 --> 2025-09-28</p><p><b>numberOfRepeatsAllowed</b>: 3</p><p><b>quantity</b>: 360 milligram per dose<span style="background: LightGoldenRodYellow"> (Details: unit codeUM10229 = 'UM10229')</span></p><h3>ExpectedSupplyDurations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Value</b></td><td><b>Unit</b></td><td><b>System</b></td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>30</td><td>days</td><td><a href="http://terminology.hl7.org/5.0.0/CodeSystem-v3-ucum.html">http://unitsofmeasure.org</a></td><td>d</td></tr></table></blockquote><h3>Substitutions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Allowed[x]</b></td><td><b>Reason</b></td></tr><tr><td style="display: none">*</td><td>true</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/v3-ActReason CT}">Continuing therapy</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://shr.dha.go.ke/fhir/medication-request"/>
<value value="bcb292cb-0707-4b90-8c35-39a82ed0f389"/>
</identifier>
<status value="active"/>
<intent value="order"/>
<medicationCodeableConcept>
<coding>
<system value="http://nhts.dha.go.ke/fhir/ValueSet/medication"/>
<code value="GE10887"/>
<display value="Empagliflozin 5 mg/Metformin 500 mg Oral Tablet"/>
</coding>
<text value="Atorvastatin 20mg tablet"/>
</medicationCodeableConcept>
<subject>
<reference value="Patient/CR6164711105276-6"/>
<identifier>
<use value="official"/>
<system value="https://hie.dha.go.ke/client-registry"/>
<value value="CR6164711105276-6"/>
</identifier>
</subject>
<authoredOn value="2025-06-30"/>
<requester>
<reference value="Practitioner/PUID-0001662-7"/>
<type value="Practitioner"/>
<identifier>
<use value="official"/>
<system value="https://hie.dha.go.ke/health-worker-registry"/>
<value value="PUID-0001662-7"/>
</identifier>
</requester>
<reasonCode>
<coding>
<system value="https://nhts.dha.go.ke/terminology/icd11"/>
<code value="I10"/>
<display value="Essential (primary) hypertension"/>
</coding>
</reasonCode>
<note>
<text value="Patient has reported nausea with higher doses in the past."/>
</note>
<dosageInstruction>
<text value="Take one tablet by mouth daily"/>
<timing>
<repeat>
<frequency value="1"/>
<period value="1"/>
<periodUnit value="d"/>
</repeat>
</timing>
<route>
<coding>
<system value="https://nhts.dha.go.ke/terminology/v1/route"/>
<code value="RT10025"/>
<display value="Oral"/>
</coding>
</route>
<doseAndRate>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/>
<code value="ordered"/>
<display value="Ordered"/>
</coding>
</type>
<doseQuantity>
<value value="20"/>
<unit value="milligram per dose"/>
<system value="https://nhts.dha.go.ke/terminology/v1/unit"/>
<code value="UM10229"/>
</doseQuantity>
</doseAndRate>
</dosageInstruction>
<dispenseRequest>
<validityPeriod>
<start value="2025-03-28"/>
<end value="2025-09-28"/>
</validityPeriod>
<numberOfRepeatsAllowed value="3"/>
<quantity>
<value value="360"/>
<unit value="milligram per dose"/>
<system value="https://nhts.dha.go.ke/terminology/v1/unit"/>
<code value="UM10229"/>
</quantity>
<expectedSupplyDuration>
<value value="30"/>
<unit value="days"/>
<system value="http://unitsofmeasure.org"/>
<code value="d"/>
</expectedSupplyDuration>
</dispenseRequest>
<substitution>
<allowedBoolean value="true"/>
<reason>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/>
<code value="CT"/>
<display value="Continuing therapy"/>
</coding>
</reason>
</substitution>
</MedicationRequest>